MSB 7.69% $1.19 mesoblast limited

Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-30

  1. 92 Posts.
    lightbulb Created with Sketch. 93
    Its not the to the moon news everyone is looking for but not bad news either. Its definitely good news because it confirms that the treatment must be working as it has not been ended due to futility.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.